Trade Names:
Synonyms:
Status: Approved (1939)
Entry Type: Oligosaccharide
Molecule Category: Salt
UNII: ZZ45AB24CA
Parent Compound: HEPARIN

Pharmacology

Action Mechanism of Action Reference
ACTIVATOR Antithrombin-III activator

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Hip Fractures 3 D006620 ClinicalTrials
Colorectal Neoplasms 3 D015179 ClinicalTrials
Kidney Failure, Chronic 3 D007676 ClinicalTrials
Thrombosis 3 D013927 ClinicalTrials
Diabetes Mellitus, Type 2 3 D003924 ClinicalTrials
Venous Thromboembolism 3 D054556 ClinicalTrials
Acute Kidney Injury 3 D058186 ClinicalTrials
Severe Acute Respiratory Syndrome 1 D045169 ClinicalTrials

Related Entries

Parent
Mixture

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Vascular disorders
26.19
Immune system disorders
10.14
General disorders and administration site conditions
9.8
Blood and lymphatic system disorders
7.83
Injury, poisoning and procedural complications
6.95
Nervous system disorders
6.83
Cardiac disorders
5.6
Respiratory, thoracic and mediastinal disorders
4.19
Gastrointestinal disorders
3.62
Investigations
3.13
Infections and infestations
2.78
Skin and subcutaneous tissue disorders
2.32

Cross References

Resources Reference
ChEMBL CHEMBL1201657
FDA SRS ZZ45AB24CA